Home

Lisa Bright

CIK 1635111 · President, International · last filed 2020-07-06

Lisa Bright is a President, International who has filed 49 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for ASND, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

49

Lifetime Open-Market Net

-$2.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted President, International 22,012 $19.00 $418.2K -$2.05M 43 2020-07-06

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-04 ASND Notice (144) −10,105 -$2.39M EDGAR
2026-03-02 ASND Notice (144) −2,100 -$508.4K EDGAR
2025-08-13 ASND Notice (144) −2,158 -$412.3K EDGAR
2025-03-04 ASND Notice (144) −1,470 -$223.6K EDGAR
2024-03-05 ASND Notice (144) −658 -$98.7K EDGAR
2024-02-29 ASND Notice (144) −10,000 -$1.46M EDGAR
2020-07-06 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −301 -$14.0K EDGAR
2020-04-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −301 -$17.6K EDGAR
2020-01-27 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +4,800 $0 EDGAR
2020-01-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −918 -$113.8K EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.